Singapore Capnography Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Hand-Held, Stand-Alone, Multi-Parameter, and Others), By Technology (Main-Stream, Side-Stream, Micro-Stream, and Others), By Application (Emergency Medicine, Pain Management, Procedural Sedation, Critical Care, and Others), and Singapore Capnography Devices Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSingapore Capnography Devices Market Insights Forecasts to 2035
- The Singapore Capnography Devices Market Size Was Estimated at USD 3.31 Million in 2024
- The Singapore Capnography Devices Market Size is Expected to Grow at a CAGR of Around 11.04% from 2025 to 2035
- The Singapore Capnography Devices Market Size is Expected to Reach USD 10.75 Million by 2035

Get more details on this report -
According to a Research Report Published by Spherical Insights & Consulting, The Singapore Capnography Devices Market Size is Anticipated to Reach USD 10.75 Million by 2035, Growing at a CAGR of 11.04% from 2025 to 2035. The Singapore capnography devices market is driven by rising respiratory diseases, increasing surgical procedures requiring anesthesia, and advancements in portable and integrated monitoring technologies.
Market Overview
The Singapore Capnography Devices Market Size encompasses the manufacture, distribution, and utilization of medical devices that measure the concentration of carbon dioxide (CO2) in a patient’s exhaled breath, enabling real-time monitoring of respiratory status. These devices are extensively used in hospitals, surgical centers, intensive care units (ICUs), and emergency care settings to enhance patient safety during anesthesia, mechanical ventilation, and critical care procedures. The market includes both mainstream and sidestream capnographs, portable and bedside systems, as well as related accessories. Market growth is driven by the increasing demand for accurate and continuous respiratory monitoring in clinical environments.
Singapore Capnography Devices Market Size is driven by rising respiratory health needs, including asthma, chronic obstructive pulmonary disease (COPD), and an increasing number of critical care cases, along with a growing aging population that requires advanced patient monitoring. The market was valued at approximately USD 3.31 million in 2024 and is projected to reach USD 10.75 million by 2035, expanding at a compound annual growth rate (CAGR) of 11.04%. The increasing volume of surgical procedures and ICU admissions, coupled with a strong emphasis on patient safety during anesthesia and mechanical ventilation, underscores the growing demand for continuous CO2 monitoring across hospitals and emergency care settings.
The Singapore government actively supports the adoption of advanced medical technologies through funding and initiatives. The National Health Innovation Centre (NHIC) provides up to S$1 million per project for clinical innovation in diagnostics and monitoring, while broader respiratory health research received S$10 million in national grants to enhance lung disease management. These programs demonstrate strong institutional backing, encouraging the integration of capnography devices into healthcare facilities, and highlight significant opportunities for growth, innovation, and technology adoption in Singapore’s respiratory care market.
Report Coverage
This research report categorizes the market for the Singapore Capnography Devices Market Size based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore capnography devices market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore capnography devices market.
Singapore Capnography Devices Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 3.31 million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | 11.04% |
| 2035 Value Projection: | USD 10.75 million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 180 |
| Tables, Charts & Figures: | 100 |
| Segments covered: | By Product ,By Technology |
| Companies covered:: | Medtronic, Philips Healthcare, Masimo Corporation, Smiths Medical (now part of ICU Medical), Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Nonin Medical, Mindray Medical, ZOLL Medical Corporation, Edan Instruments, Inc., Becton, Dickinson and Company (BD), Criticare Technologies, and Other Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The Singapore capnography devices market is driven by the growing prevalence of respiratory diseases like asthma and COPD. Increasing surgical procedures and ICU care further boost demand. Advancements in portable and integrated monitoring technologies are also accelerating adoption.
Restraining Factors
The Singapore Capnography Devices Market Size faces restraints such as high device and maintenance costs, limited awareness among smaller clinics, and the complexity of integration with existing hospital systems. Additionally, a shortage of trained personnel to operate and interpret capnography readings can slow adoption.
Market Segmentation
The Singapore Capnography Devices Market share is classified into product, technology, and application.
- The stand-alone segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Singapore Capnography Devices Market Size is segmented by product into handheld, stand-alone, multi-parameter, and others. Among these, the stand-alone segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The stand-alone segment is growing because it offers dedicated, accurate, and continuous CO2 monitoring during surgeries and critical care, ensuring patient safety. Its reliability, ease of use in hospitals, and compatibility with existing ventilation systems drive higher adoption and revenue.
- The side-stream segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.
The Singapore Capnography Devices Market Size is segmented by technology into main-stream, side-stream, micro-stream, and others. Among these, the side-stream segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The side-stream segment is growing because it is less invasive, cost-effective, and compatible with a wide range of patients and ventilators. Its flexibility for use in ICUs, operating rooms, and emergency settings, along with reliable CO2 monitoring, drives widespread adoption.
- The critical care segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Singapore Capnography Devices Market Size is segmented by application into emergency medicine, pain management, procedural sedation, critical care, and others. Among these, the critical care segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The critical care segment is growing because ICUs and intensive care units increasingly rely on continuous CO2 monitoring to manage patients on mechanical ventilation and those with severe respiratory conditions. Rising critical care admissions and emphasis on patient safety further drive demand for capnography devices.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Singapore capnography devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Medtronic
- Philips Healthcare
- Masimo Corporation
- Smiths Medical (now part of ICU Medical)
- Drägerwerk AG & Co. KGaA
- Nihon Kohden Corporation
- Nonin Medical
- Mindray Medical
- ZOLL Medical Corporation
- Edan Instruments, Inc.
- Becton, Dickinson and Company (BD)
- Criticare Technologies
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Singapore, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Singapore Capnography Devices Market Size based on the below-mentioned segments:
Singapore Capnography Devices Market, By Product
- Hand-held
- Stand-alone
- Multi-parameter
- Others
Singapore Capnography Devices Market, By Technology
- Main-Stream
- Side-Stream
- Micro-Stream
- Others
Singapore Capnography Devices Market, By Application
- Emergency Medicine
- Pain Management
- Procedural Sedation
- Critical Care
- Others
Frequently Asked Questions (FAQ)
-
1. What is the Singapore capnography devices market size in 2024?The Singapore capnography devices market size was estimated at USD 3.31 million in 2024.
-
2. What is the projected market size of the Singapore capnography devices market by 2035?The Singapore capnography devices market size is expected to reach USD 10.75 million by 2035.
-
3. What is the CAGR of the Singapore capnography devices market?The Singapore capnography devices market size is expected to grow at a CAGR of around 11.04% from 2024 to 2035.
-
4. What are the key growth drivers of the Singapore capnography devices market?The Singapore capnography devices market is driven by rising respiratory diseases, increasing surgical procedures requiring anesthesia, and advancements in portable and integrated monitoring technologies.
-
5. Which technology segment dominated the market in 2024?The side-stream segment dominated the market in 2024.
-
7. What segments are covered in the Singapore capnography devices market report?The Singapore capnography devices market is segmented on the basis of product, technology, and application.
-
8. Who are the key players in the Singapore capnography devices market?Key companies include Medtronic, Philips Healthcare, Masimo Corporation, Smiths Medical (now part of ICU Medical), Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Nonin Medical, Mindray Medical, ZOLL Medical Corporation, Edan Instruments, Inc., Becton, Dickinson and Company (BD), Criticare Technologies, and others.
Need help to buy this report?